Inventor
BUCHHOLZ URSULA J
US17 patents
⚠️ This page may combine multiple inventors who share the name “BUCHHOLZ URSULA J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
8 patentsUS9957486B2May 1, 2018
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
US HEALTH9 citations80
US10307476B2Jun 4, 2019
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
US HEALTH1 citations70
US11975063B2May 7, 2024
Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use
US HEALTH0 citations61
US10980872B2Apr 20, 2021
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
US HEALTH0 citations60
US12071632B2Aug 27, 2024
Chimeric vectors
US HEALTH0 citations59
US11332721B2May 17, 2022
Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
US HEALTH0 citations57
US9624475B2Apr 18, 2017
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
US HEALTH0 citations49
US10655109B2May 19, 2020
Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
US HEALTH0 citations46
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES
4 patentsUS10808012B2Oct 20, 2020
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES4 citations81
US11371024B2Jun 28, 2022
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES3 citations69
US11390651B2Jul 19, 2022
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations59
US12054519B2Aug 6, 2024
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES0 citations58
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
2 patentsUS11273214B2Mar 15, 2022
Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES0 citations61
US12054749B2Aug 6, 2024
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES0 citations58